Cargando…

Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for Identifying Benign and Malignant Breast Lesions of Sub-1 cm

OBJECTIVES: To develop a radiomics nomogram that incorporates contrast-enhanced spectral mammography (CESM)-based radiomics features and clinico-radiological variables for identifying benign and malignant breast lesions of sub-1 cm. METHODS: This retrospective study included 139 patients with the di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Fan, Wang, Zhongyi, Zhang, Kun, Yang, Ping, Ma, Heng, Shi, Yinghong, Liu, Meijie, Wang, Qinglin, Cui, Jingjing, Mao, Ning, Xie, Haizhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662120/ https://www.ncbi.nlm.nih.gov/pubmed/33194677 http://dx.doi.org/10.3389/fonc.2020.573630

Ejemplares similares

Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for the Prediction of Neoadjuvant Chemotherapy-Insensitive Breast Cancers
por: Wang, Zhongyi, et al.
Publicado: (2021)

Radiomics Nomogram for Identifying Sub-1 cm Benign and Malignant Thyroid Lesions
por: Wu, Xinxin, et al.
Publicado: (2021)

Radiomic Analysis of Contrast-Enhanced Mammography With Different Image Types: Classification of Breast Lesions
por: Wang, Simin, et al.
Publicado: (2021)

Radiomics of contrast-enhanced spectral mammography for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer
por: Zhang, Kun, et al.
Publicado: (2023)

Diagnostic Value of Contrast-Enhanced Spectral Mammography in Comparison to Magnetic Resonance Imaging in Breast Lesions
por: Xing, Dong, et al.
Publicado: (2019)

Diagnostic Value of Radiomics Analysis in Contrast-Enhanced Spectral Mammography for Identifying Triple-Negative Breast Cancer
por: Zhang, Yongxia, et al.
Publicado: (2021)

Can Contrast-Enhanced Spectral Mammography (CESM) Reduce Benign Breast Biopsy?
por: Liew, Amanda Ling Fung, et al.
Publicado: (2022)

Radiomic Analysis in Contrast-Enhanced Spectral Mammography for Predicting Breast Cancer Histological Outcome
por: La Forgia, Daniele, et al.
Publicado: (2020)

Pharmacokinetic parameters and radiomics model based on dynamic contrast enhanced MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer
por: Liu, Meijie, et al.
Publicado: (2020)

Radiomic Feature Reduction Approach to Predict Breast Cancer by Contrast-Enhanced Spectral Mammography Images
por: Massafra, Raffaella, et al.
Publicado: (2021)

A CT-based radiomics nomogram for differentiation of benign and malignant small renal masses (≤4 cm)
por: Feng, Shengxing, et al.
Publicado: (2023)

Radiomics Analysis on Contrast-Enhanced Spectral Mammography Images for Breast Cancer Diagnosis: A Pilot Study
por: Losurdo, Liliana, et al.
Publicado: (2019)

Contrast-Enhanced Spectral Mammography: Comparison with Conventional Mammography and Histopathology in 152 Women
por: Luczyńska, Elzbieta, et al.
Publicado: (2014)

Degree of Enhancement on Contrast Enhanced Spectral Mammography (CESM) and Lesion Type on Mammography (MG): Comparison Based on Histological Results
por: Łuczyńska, Elżbieta, et al.
Publicado: (2016)

Comparison between Breast MRI and Contrast-Enhanced Spectral Mammography
por: Łuczyńska, Elżbieta, et al.
Publicado: (2015)

Contrast-enhanced spectral mammography with a compact synchrotron source
por: Heck, Lisa, et al.
Publicado: (2019)

Initial outcome of contrast-enhanced spectral mammography in lesion characterisation in the mammographically dense breast
por: Hussain, Zeiad, et al.
Publicado: (2015)

Contrast-enhanced spectral mammography: are kinetic patterns useful for differential diagnoses of enhanced lesions?
por: Rong, Xiaocui, et al.
Publicado: (2023)

A Radiomics Nomogram for Distinguishing Benign From Malignant Round-Like Breast Tumors
por: Wang, Lanyun, et al.
Publicado: (2022)

Radiomic Features Applied to Contrast Enhancement Spectral Mammography: Possibility to Predict Breast Cancer Molecular Subtypes in a Non-Invasive Manner
por: Nicosia, Luca, et al.
Publicado: (2022)

Quantitative Analysis of Enhancement Intensity and Patterns on Contrast-enhanced Spectral Mammography
por: Liu, Ying, et al.
Publicado: (2020)

Contrast-Enhanced Spectral Mammography: Importance of the Assessment of Breast Tumor Size
por: Nicosia, Luca, et al.
Publicado: (2021)

Radiomics and Artificial Intelligence Analysis with Textural Metrics Extracted by Contrast-Enhanced Mammography in the Breast Lesions Classification
por: Fusco, Roberta, et al.
Publicado: (2021)

Comparison of Contrast-Enhanced Spectral Mammography and Contrast-Enhanced MRI in Screening Multifocal and Multicentric Lesions in Breast Cancer Patients
por: Feng, Lei, et al.
Publicado: (2022)

Radiomics Nomogram of DCE-MRI for the Prediction of Axillary Lymph Node Metastasis in Breast Cancer
por: Mao, Ning, et al.
Publicado: (2020)

Contrast enhanced mammography: focus on frequently encountered benign and malignant diagnoses
por: Yang, Mindy L., et al.
Publicado: (2023)

Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions
por: Li, Tianping, et al.
Publicado: (2022)

Mammography-based radiomics nomogram: a potential biomarker to predict axillary lymph node metastasis in breast cancer
por: Tan, Hongna, et al.
Publicado: (2020)

Diagnostic accuracy of contrast-enhanced spectral mammography for breast lesions: A systematic review and meta-analysis
por: Suter, Matteo Basilio, et al.
Publicado: (2020)

The effectiveness of contrast-enhanced spectral mammography and magnetic resonance imaging in dense breasts
por: Rudnicki, Wojciech, et al.
Publicado: (2021)

Contrast-Enhanced Spectral Mammography in the Evaluation of Breast Microcalcifications: Controversies and Diagnostic Management
por: Nicosia, Luca, et al.
Publicado: (2023)

A Score to Predict the Malignancy of a Breast Lesion Based on Different Contrast Enhancement Patterns in Contrast-Enhanced Spectral Mammography
por: Nicosia, Luca, et al.
Publicado: (2022)

Retrospective Comparison of Contrast-Enhanced Spectral Mammography with Digital Mammography in Assessing Tumor Size in 668 Cases of Breast Cancer
por: Lorek, Andrzej, et al.
Publicado: (2020)

A Nomogram Based on a Multiparametric Ultrasound Radiomics Model for Discrimination Between Malignant and Benign Prostate Lesions
por: Liang, Lei, et al.
Publicado: (2021)

Contrast-Enhanced Spectral Mammography Versus Ultrasonography: Diagnostic Performance in Symptomatic Patients with Dense Breasts
por: Lu, Zhongfei, et al.
Publicado: (2020)

Multi-modality radiomics nomogram based on DCE-MRI and ultrasound images for benign and malignant breast lesion classification
por: Liu, Xinmiao, et al.
Publicado: (2022)

A CT-based radiomics nomogram for distinguishing between benign and malignant bone tumours
por: Sun, Weikai, et al.
Publicado: (2021)

Contrast-Enhanced Spectral Mammography Assessment of Patients Treated with Neoadjuvant Chemotherapy for Breast Cancer
por: Steinhof-Radwańska, Katarzyna, et al.
Publicado: (2021)

A Nomogram Based on Radiomics with Mammography Texture Analysis for the Prognostic Prediction in Patients with Triple-Negative Breast Cancer
por: Jiang, Xian, et al.
Publicado: (2020)

Preclinical study of diagnostic performances of contrast-enhanced spectral mammography versus MRI for breast diseases in China
por: Wang, Qingguo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g49dlsrv75l3anjff0k08dti9v